OBJECTIVE: The aim of this work was to determine whether minority women are more likely to die of cervical cancer. A population-based cohort study was performed using Texas Cancer Registry (TCR) data from 1998 to 2002. METHODS: A total of 5,166 women with cervical cancer were identified during 1998-2002 through the TCR. Measures of socioeconomic status (SES) and urbanization were created using census block group-level data. Multilevel logistic regression was used to calculate the odds of dying from cervical cancer by race, and Cox proportional hazards modeling was used for cervical cancer-specific survival analysis. RESULTS: After adjusting for age, SES, urbanization, stage, cell type, and treatment, Hispanic women were significantly less likely than non-Hispanic White women to die from cervical cancer (adjusted hazard ratio [aHR] = 0.69; 95% CI [confidence interval] = 0.59-0.80), whereas Black women were more likely to die (aHR = 1.26; 95% CI = 1.06-1.50). Black and Hispanic women were more likely to be diagnosed at a later stage than White women. Black women were significantly less likely to receive surgery among those diagnosed with localized disease (p = 0.001) relative to both White and Hispanic women. CONCLUSIONS: Relative to non-Hispanic White women, Black women were more likely to die of cervical cancer while Hispanic women were less likely to die; these survival differences were not explained by SES, urbanization, age, cell type, stage at diagnosis, or treatment.
OBJECTIVE: The aim of this work was to determine whether minority women are more likely to die of cervical cancer. A population-based cohort study was performed using Texas Cancer Registry (TCR) data from 1998 to 2002. METHODS: A total of 5,166 women with cervical cancer were identified during 1998-2002 through the TCR. Measures of socioeconomic status (SES) and urbanization were created using census block group-level data. Multilevel logistic regression was used to calculate the odds of dying from cervical cancer by race, and Cox proportional hazards modeling was used for cervical cancer-specific survival analysis. RESULTS: After adjusting for age, SES, urbanization, stage, cell type, and treatment, Hispanic women were significantly less likely than non-Hispanic White women to die from cervical cancer (adjusted hazard ratio [aHR] = 0.69; 95% CI [confidence interval] = 0.59-0.80), whereas Black women were more likely to die (aHR = 1.26; 95% CI = 1.06-1.50). Black and Hispanic women were more likely to be diagnosed at a later stage than White women. Black women were significantly less likely to receive surgery among those diagnosed with localized disease (p = 0.001) relative to both White and Hispanic women. CONCLUSIONS: Relative to non-Hispanic White women, Black women were more likely to die of cervical cancer while Hispanic women were less likely to die; these survival differences were not explained by SES, urbanization, age, cell type, stage at diagnosis, or treatment.
Authors: A V Diez-Roux; C I Kiefe; D R Jacobs; M Haan; S A Jackson; F J Nieto; C C Paton; R Schulz; A V Roux Journal: Ann Epidemiol Date: 2001-08 Impact factor: 3.797
Authors: J H Farley; J F Hines; R R Taylor; J W Carlson; M F Parker; E R Kost; S J Rogers; T A Harrison; C I Macri; G P Parham Journal: Cancer Date: 2001-02-15 Impact factor: 6.860
Authors: Kendra L Schwartz; Heather Crossley-May; Fawn D Vigneau; Karl Brown; Mousumi Banerjee Journal: Cancer Causes Control Date: 2003-10 Impact factor: 2.506
Authors: Stephanie A Robert; Indiana Strombom; Amy Trentham-Dietz; John M Hampton; Jane A McElroy; Polly A Newcomb; Patrick L Remington Journal: Epidemiology Date: 2004-07 Impact factor: 4.822
Authors: Shaina F Bruce; Tanvi V Joshi; Inna Chervoneva; Misung Yi; Sudeshna Chatterjee-Paer; Elizabeth R Burton; Mitchell I Edelson; Joel I Sorosky; Mark S Shahin Journal: Obstet Gynecol Date: 2019-09 Impact factor: 7.623
Authors: Sarah C Markt; Tianyu Tang; Angel M Cronin; Ingrid T Katz; Brooke E Howitt; Neil S Horowitz; Larissa J Lee; Alexi A Wright Journal: PLoS One Date: 2018-02-15 Impact factor: 3.240
Authors: Janaka Weragoda; Andres Azuero; Suguna Badiga; Walter C Bell; Roland Matthews; Chandrika Piyathilake Journal: Cancer Med Date: 2016-05-17 Impact factor: 4.452